References and Notes
1
Handbook of
Porphyrin Science
Vol. 4 and 12:
Kadish K.
Smith KM.
Guilard R.
World Scientific
Publishing Company;
Singapore:
2010.
2a
Tomé AC.
Neves MGPMS.
Cavaleiro JAS.
J. Porphyrins Phthalocyanines
2009,
13:
408
2b
Cavaleiro JAS.
Tomé AC.
Neves MGPMS. In
Handbook of Porphyrin Science
Vol.
2:
Kadish K.
Smith KM.
Guilard R.
World
Scientific Publishing Company;
Singapore:
2010.
p.193
3a
Ferreira VF.
Ferreira SB.
da Silva FC.
Org. Biomol.
Chem.
2010,
8:
4793 ;
and references cited therein
3b
Salas CO.
Faúndez M.
Morello A.
Maya JD.
Tapia RA.
Curr. Med. Chem.
2011,
18:
144
4a
Kady MM.
Brimer L.
Furu P.
Lemmich S.
Nieslen HM.
Thiilborg ST.
Thastrup O.
Christenesen SB.
Planta
Med.
1992,
58:
334
4b
Mahmoud AA.
Ahmed AA.
Linuma M.
Tanaka T.
Phytochemistry
1998,
47:
543
5a
Florence X.
Sebille S.
de Tullio P.
Lebrun P.
Pirotte B.
Bioorg. Med. Chem.
2009,
17:
7723
5b
Rapposelli S.
Breschi MC.
Calderone V.
Digiacomo M.
Martelli A.
Testai L.
Vanni M.
Balsamo A.
Eur. J. Med. Chem.
2011,
46:
966
6a
Rokita SE.
Quinone
Methides
Wiley;
Hoboken:
2009.
6b
Tietze LF.
Rackelman N. In
Multicomponent Reactions
Zhu J.
Bienaymé H.
Wiley-VCH;
Weinheim:
2005.
p.121
6c
da Silva FC.
Ferreira SB.
Kaiser CR.
Pinto AC.
Ferreira VF.
J.
Braz. Chem. Soc.
2009,
20:
1478
6d
Ferreira SB.
da Silva FC.
Bezerra FAFM.
Lourenco MCS.
Kaiser CR.
Pinto AC.
Ferreira VF.
Arch. Pharm. Chem. Life Sci.
2010,
343:
81
6e
Appendino G.
Cravotto G.
Toma L.
Annunziata R.
Palmisano G.
J.
Org. Chem.
1994,
59:
5556
6f
Khoshkholgh MJ.
Lotfi M.
Balalaie S.
Rominger F.
Tetrahedron
2009,
65:
4228
6g
Yadav JS.
Reddy BVS.
Narsimhaswamy D.
Lakshmi PN.
Narsimulu K.
Srinivasulu G.
Kunwar AC.
Tetrahedron Lett.
2004,
45:
3493
7
Tomé AC.
Lacerda PSS.
Neves MGPMS.
Cavaleiro JAS.
Chem. Commun.
1997,
1199
8a
Faustino MAF.
Neves MGPMS.
Tomé AC.
Silva AMS.
Cavaleiro JAS.
ARKIVOC
2005,
(ix):
332
8b
Oliveira KT.
Silva AMS.
Tomé AC.
Neves MGPMS.
Neri CR.
Garcia VS.
Serra OA.
Iamamoto Y.
Cavaleiro JAS.
Tetrahedron
2008,
64:
8709
9
Callot HJ.
Tetrahedron
1973,
29:
899
10
General Procedure
for Preparing Compounds 8, 9, and 10a,b
In a round-bottom
flask, equipped with a magnetic stirring bar, a solution of 2-hydroxy-1,4-naphthoquinone
(1, 6.2 mg, 35.5 µmol) [or
4-hydroxycoumarins (2a, 5.7 mg; 2b, 6.2 mg; 35.5 µmol)],
1,4-dioxane (5 mL), paraformaldehyde (8.5 mg, 284 µmol),
and porphyrin 4 (25 mg, 35.5 µmol)
was heated at reflux until consumption of the starting porphyrin 4 (1-48 h). Quinone methide precursors
were added at regular intervals. Dioxane was then removed under
reduced pressure, CHCl3 (50 mL) was added to the residue,
and the mixture was washed with sat. aq NaHCO3 (2 × 20
mL). The organic phase was concentrated under vacuum, and the residual
crude product was purified by column chromatog-raphy on silica gel
and subsequently by preparative TLC using CHCl3 as the
eluent.
11
Wang H.
Wang Y.
Han KL.
Peng XJ.
J. Org. Chem.
2005,
70:
4910
12 Unequivocal proton and carbon assignments
for all compounds were based on two-dimensional COSY, HSQC, and
HMBC experiments.
Data for {2-(5,10-Dioxo-3,4,5,10-tetrahydro-2
H
-benzo[
g
]chromen-2-yl)-5,10,15,20-tetraphenylporphyrinato}zinc(II) (8)
¹H NMR
(300 MHz, CDCl3): δ = 2.12-2.32
(m, 2 H, H-3′ and H-4′), 2.54-2.79 (m,
2 H, H-3′ and H-4′), 4.95 (d, J = 8.3 Hz,
1 H, H-2′), 7.49-7.54 (m, 1 H, Hp-Ph),
7.65-7.76 (m, 13 H, Hm,p-Ph, H-7′ and H-8′),
8.07-8.11 (m, 2 H, H-6′ and H-9′), 8.14-8.23
(m, 8 H, Ho-Ph), 8.73 (d, J = 4.8 Hz,
1 H, H-β), 8.89 (d, J = 4.8
Hz, 1 H, H-β), 8.92 (d, J = 4.8
Hz, 1 H, H-β), 8.93 (s, 2 H, H-12 and H-13), 8.95 (d, J = 4.8 Hz,
1 H, H-β), 9.12 (s, 1 H, H-3). ¹³C
NMR (75 MHz, CDCl3): δ = 20.2
(C-4′), 29.4 (C-3′), 75.8 (C-2′), 120.4,
121.1, 121.2, 121.5, 121.7 (C-4′a and 2 C-quat), 126.0,
126.2, 126.3, 126.4, 126.6, 126.65, 126.7, 127.5, 128.3 (Co-Ph, Cm,p-Ph, C-6′, C-9′),
131.1; 131.6, 132.0, 132.2, 132.2, 132.5 (C-β), 132.9 (Co-Ph, C-3), 133.0, 133.3, 133.8, 134.4,
134.42, 134.7 (C-7′, C-8′, Co-Ph,
Cm,p-Ph),
142.5, 142.6, 142.7,143.3 (C-1), 145.8, 147.9, 150.3, 150.4, 150.5,
150.6, 150.9, 156.2 (C-10a′), 179.5 (C-5′), 184.5
(C-10′); UV/vis (CHCl3): λmax (log ε) = 424
(4.94), 554 (4.57), 597 (3.96) nm. HRMS (ESI+): m/z [M + H]+ calcd
for C57H37N4O3Zn: 889.2152;
found: 889.2143.
Data for {2-(5,6-Dioxo-3,4,5,6-tetrahydro-2
H
-benzo[
h
]chromen-2-yl)-5,10,15,20-tetraphenylporphyrinato}zinc(II) (9)
¹H NMR
(500 MHz, CDCl3): δ = 2.16-2.24
(m, 2 H, H-3′ and H-4′), 2.58-2.61 (m,
1 H, H-3′), 2.71-2.75 (m, 1 H, H-4′),
5.08 (d, J = 10.2
Hz, 1 H, H-2′), 7.47-7.51 (m, 2 H, H-8′,
1 Hp-Ph), 7.55 (dt, J = 7.6,
1.6 Hz, 1 H, H-9′), 7.71-7.81 (m, 12 H, Hm,p-Ph, H-10′),
8.09 (dd, J = 7.6,
1.3 Hz, 1 H, H-7′), 8.16-8.24 (m, 8 H, Ho-Ph), 8.76 (d, J = 4.6
Hz, 1 H, H-β), 8.91 (d, J = 4.6
Hz, 1 H, H-β), 8.95 (s, 2 H, H-12 and H-13), 8.96 (d, J = 4.6 Hz,
1 H, H-β), 8.97 (d, J = 4.6
Hz, 1 H, H-β), 9.14 (d, J = 0.7
Hz, 1 H, H-3). ¹³C NMR (125 MHz, CDCl3): δ = 19.8
(C-4′), 29.8 (C-3′), 76.9 (C-2′), 114.2
(C-4′a), 120.4, 121.1, 121.4, 121.7, 124.2 (C-10′),
126.4, 126.5, 126.6, 126.7, 127.6, 127.7 (Cm,p-Ph), 128.6, 128.7 (Cm,p-Ph, C-7′), 129.9 (C-6′a),
130.6 (C-8′), 131.8, 132.27, 132.30, 132.33, 132.4, 132.43
(C-β), 132.6 (C-3, C-10′a), 133.4, 133.5, 134.36,
134.4, 134.42; 134.5 (C-o), 134.75 (C-9′), 142.3,
142.5, 142.7, 143.2 (C-1), 145.5, 147.7, 150.21, 150.4, 150.57,
150.6, 150.7, 150.8, 163.6 (C-10b′), 178.7 (C-5′),
179.7 (C-6′); UV/vis (CHCl3): λmax (log ε):
424 (4.85), 552 (4.52), 596 (3.96) nm. HRMS (ESI+): m/z [M + H]+ calcd
for C57H37N4O3Zn: 889.2152;
found: 889.2122.
13
Data for {2-(5-Oxo-2,3,4,5-tetrahydro-2
H
-pyrano[3,2-
c
]chromen-2-yl)-5,10,15,20-tetraphenylporphyrinato}zinc(II) (10a)
¹H NMR
(500 MHz, CDCl3): δ = 2.25-2.29
(m, 2 H, H-3′ and H-4′), 2.61-2.67 (m,
2 H, H-3′ and H-4′), 5.04 (d, J = 8.5 Hz,
1 H, H-2′), 7.19 (ddd, J = 8.1,
7.2, 1.0 Hz, 1 H, H-9′), 7.34 (dd, J = 8.5,
1.0 Hz, 1 H, H-7′), 7.40-7.45 (m, 1 H, Hp-Ph), 7.49 (ddd, J = 8.5,
7.2, 1.4 Hz, 1 H, H-8′), 7.71-7.81 (m, 12 H, Hm,p-Ph, H-10′),
8.16-8.23 (m, 8 H, Ho-Ph), 8.75
(d, J = 4.6
Hz, 1 H, H-β), 8.90 (d, J = 4.6
Hz, 1 H, H-β), 8.94 (s, 2 H, H-12 and H-13), 8.95 (d, J = 4.6 Hz,
1 H, H-β), 8.97 (d, J = 4.6
Hz, 1 H, H-β), 9.15 (d, J = 0.5
Hz, 1 H, H-3). ¹³C NMR (125 MHz, CDCl3): δ = 20.9
(C-3′), 30.0 (C-4′), 75.9 (C-2′), 101.2
(C-4′a), 115.9 (C-10′a), 116.5 (C-7′),
120.5, 121.1, 121.3, 121.6, 122.5 (C-10′), 123.7 (C-9′),
126.4, 126.5, 126.6, 126.7, 127.6, 127.7, 128.5 (Cm,p-Ph), 131.2 (C-8′), 131.7,
132.3, 132.35, 132.6 (C-β), 133.4, 133.5, 134.37, 134.4,
134.42, 134.47, 134.5 (Co-Ph), 142.3,
142.4, 142.5, 142.7, 143.5 (C-1), 145.6, 147.8, 150.2, 150.4, 150.5, 150.6,
150.9, 152.4 (C-6′a), 160.7 (C-10′b), 163.4 (C-5′). UV/vis
(CHCl3): λmax (log ε): 425
(4.94), 555 (4.54), 596 (4.00) nm. HRMS (ESI+): m/z [M + H]+ calcd
for C56H37N4O3Zn: 877.2152;
found: 877.2116.
14
Van de Waters RW.
Pettus TRR.
Tetrahedron
2002,
58:
5367 ; and references cited therein
15
General Procedure
for Preparing 11a-c
A mixture of porphyrin 4 (10 mg, 14.2 µmol) and appropriate
benzyl alcohol (3a, 1.7 mg; 3b,
2.2 mg; 14.2 µmol) was refluxed in o-dichlorobenzene
(3 mL) in a sealed tube until consumption of starting porphyrin 4 (monitored by TLC) with addition of quinone
methide precursors at regular intervals. After completion of reaction
(6-26 h) the mixture was loaded on a silica column or preparative
TLC plate and eluted with PE. Further elution with CHCl3 gave
the corresponding adducts.
16
Data for [2-(Chroman-2-yl)-5,10,15,20-tetraphenylporphyrinato]zinc(II) (11a)
¹H NMR
(300 MHz, CDCl3): δ = 2.14-2.26
(m, 1 H, H-3′), 2.43-2.55 (m, 1 H, H-3′),
2.56-2.74 (m, 2 H, H-4′), 4.95 (d, J = 9.6 Hz,
1 H, H-2′), 6.85-6.94 (m,2 H, H-6′ and
H-8′), 7.07-7.21 (m, 2 H, H-5′ and
H-7′), 7.53-7.59 (m, 1 H, Hp-Ph),
7.68-7.80 (m, 11 H, Hm,p-Ph), 8.15-8.23 (m, 8 H, Ho-Ph), 8.73 (d, J = 4.7
Hz, 1 H, H-β), 8.89 (d, J = 4.7
Hz, 1 H, H-β), 8.91 (d, J = 4.7
Hz, 1 H, H-β), 8.92 (s, 2 H, H-12 and H-13), 8.95 (d, J = 4.7 Hz,
1 H, H-β), 9.16 (s, 1 H, H-3). ¹³C NMR
(75 MHz, CDCl3): δ = 26.2
(C-4′), 31.7 (C-3′), 74.2 (C-2′), 117.1
(C-8′), 120.0 (C-6′), 120.6, 120.9, 121.1, 121.5, 122.1
(C-4′a), 126.1, 126.5, 126.55, 127.0, 127.5, 128.1 (C-7′,
Cm,p-Ph),
129.5 (C-5′), 131.5, 131.9, 132.0, 132.1, 132.4, 132.5
(C-β), 133.3, 133.7, 134.3, 134.4, 134.42, 134.6 (Co-Ph), 142.6, 142.7, 142.8, 145.9, 146.5
(C-1), 148.4, 150.0, 150.2, 150.3, 150.5, 150.9, 155.6 (C-8′a).
UV/vis (CHCl3): λmax (log ε):
420 (4.98), 548 (4.59) nm. HRMS (ESI+): m/z [M + H]+ calcd
for C53H37N4Ozn: 809.2253; found:
809.2273.
17
Data for {2-[8-(2-Hydroxybenzyl)chroman-2-yl)]-5,10,15,20-tetraphenylporphyrinato}zinc(II) (11c)
¹H NMR
(300 MHz, CDCl3): δ = 2.17-2.75
(m, 4 H, H-3′and H-4′), 3.79 (d, J = 14.4
Hz, 1 H, CH2), 3.92 (d, J = 14.4
Hz, 1 H, CH2), 4.97 (dd, J = 10.4,
1.1 Hz, 1 H, H-2′), 6.47 (dd, J = 8.0,
1.1 Hz, 1 H, H-3′′), 6.75 (dt, J = 7.5, 1.1
Hz, 1 H, H-5′′), 6.84 (t, J = 7.4
Hz, 1 H, H-6′), 6.87 (s, 1 H, OH), 6.93-6.97 (m,
2 H, H-5′ and H-4′′),
7.12 (dd, J = 7.4,
1.4 Hz, 1 H, H-7′), 7.20 (dd, J = 7.5,
1.6 Hz, 1 H, H-6′′), 7.52-7.55 (m, 1
H, Hp-Ph), 7.66-7.76 (m, 11
H, Hm,p-Ph),
8.17-8.33 (m, 8 H, Ho-Ph), 8.77
(d, J = 4.7
Hz, 1 H, H-β), 8.89 (d, J = 4.7
Hz, 1 H, H-β), 8.93 (s, 2 H, H-β), 8.95 (s, 2
H, H-β), 9.26 (s, 1 H, H-3). ¹³C
NMR (75 MHz, CDCl3): δ = 26.3
(C-4′), 30.5 (CH2), 31.2 (C-3′), 75.3
(C-2′), 116.4 (C-3′′), 120.3 (C-5′′),
120.6, 120.8 (C-6′), 121.07, 121.13, 121.4, 122.2 (C-4′a),
126.2, 126.4, 126.5 (Cm,p-Ph),
127.0 (Cm,p-Ph,
C-1′′), 127.5, 127.6, 127.8 (C-8′), 128.1
(C-4′′,
C-7′, C-5′,
Cm,p-Ph),
128.2, 130.4 (C-6′′), 130.5; 131.5, 132.06, 132.1,
132.2, 132.4 (C-β), 132.8 (C-3), 133.4, 133.6, 134.4, 134.5,
134.9 (Co-Ph), 142.8, 142.9, 144.9, 145.8, 148.1,
150.2, 150.2, 150.4, 150.4, 150.5, 150.8, 151.6 (C-8′a),
154.0 (C-2′′). UV/vis (CHCl3): λmax (log ε):
420 (5.72), 547 (4.59) nm. HRMS (ESI+): m/z [M]+ calcd
for C60H42N4O2Zn: 914.2594;
found: 914.2583.
18
Dorrestijn E.
Kranenburg M.
Ciriano MV.
Mulder P.
J. Org. Chem.
1999,
64:
3012